Lv Dian-Yi, Qin Mao-Quan, Wang Yan, Gao Li-Wei, Xie Zheng-De
Beijing Children's Hospital Affiliated to Capital Medical University, Beijing 100045, China.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Dec;24(6):455-7.
To study the incidence of human cytomegalovirus (CMV) and human herpesvirus 6 (HHV-6) infection in pediatric patients with hemopoietic stem cell transplantation (HSCT), and to explore the relationship between CMV and HHV-6 infection in pediatric patients with HSCT.
Pediatric patients with HSCT in hemotology center of Beijing Children's Hospital were enrolled into this study from June 2007 to October 2009. Peripheral blood were collected every week after HSCT, and Fluorescent quantitation PCR and conventional PCR were used to detect CMV DNA load in serum and HHV-6 DNA in peripheral blood respectively. Genetic typing was conducted on HHV-6.
Fifty two pediatric patients with HSCT were enrolled into this study, and six hundreds and thirty six specimens were collected totally. CMV DNA was detected in fifty two specimens from twenty cases. The median time was 56 days after HSCT. The incidence of CMV infection was 38.5% (20/52) in all HSCT patients and 47.6% (20/42) in allogene HSCT patients. The incidence of late CMV infection was 22.2% (6/27) in allogene HSCT. Three patients died of CMV infection,and two died of CMV interstitial pneumonia. HHV-6 DNA was detected in thirty three specimens from fourteen cases. The median time was 23 days after HSCT. The incidence of HHV-6 infection was 26.9% (14/52)in all HSCT patients and 31% (13/42) in allogene HSCT patients. The genotype of HHV6 was all type B. HHV-6 DNA was positive in six of twenty cases with CMV infection. The incidence of co-infection was 30% (6/20).
There was a substantial incidence of CMV and HHV6 infection after HSCT. The relationship between earlier HHV6 infection and later CMV infection in pediatric patients with HSCT need further study.
研究造血干细胞移植(HSCT)患儿中人巨细胞病毒(CMV)和人疱疹病毒6型(HHV-6)感染的发生率,并探讨HSCT患儿中CMV与HHV-6感染之间的关系。
选取2007年6月至2009年10月在北京儿童医院血液科接受HSCT的患儿纳入本研究。HSCT后每周采集外周血,分别采用荧光定量PCR和常规PCR检测血清中CMV DNA载量及外周血中HHV-6 DNA。对HHV-6进行基因分型。
52例接受HSCT的患儿纳入本研究,共采集标本636份。20例患儿的52份标本检测到CMV DNA。中位时间为HSCT后56天。所有HSCT患者中CMV感染发生率为38.5%(20/52),异基因HSCT患者中为47.6%(20/42)。异基因HSCT中晚期CMV感染发生率为22.2%(6/27)。3例患者死于CMV感染,2例死于CMV间质性肺炎。14例患儿的33份标本检测到HHV-6 DNA。中位时间为HSCT后23天。所有HSCT患者中HHV-6感染发生率为26.9%(14/52),异基因HSCT患者中为31%(13/42)。HHV6基因型均为B型。20例CMV感染患儿中有6例HHV-6 DNA阳性。合并感染发生率为30%(6/20)。
HSCT后CMV和HHV6感染发生率较高。HSCT患儿中早期HHV6感染与晚期CMV感染之间的关系有待进一步研究。